These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8882956)

  • 1. Accuracy of immunohistochemistry and flow cytometry in estimating the proportion of leukemic cells in S phase in chronic myeloid leukemia patients.
    Hegde U; Kotelnikov VM; Handa H; Burke P; Preisler HD
    Leuk Lymphoma; 1996 Aug; 22(5-6):431-7. PubMed ID: 8882956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunohistochemical staining pattern of Gab2 correlates with distinct stages of chronic myeloid leukemia.
    Aumann K; Lassmann S; Schöpflin A; May AM; Wöhrle FU; Zeiser R; Waller CF; Hauschke D; Werner M; Brummer T
    Hum Pathol; 2011 May; 42(5):719-26. PubMed ID: 21292300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescence in situ hybridization (FISH) detection of trisomy 8 in myeloid cells in chronic myeloid leukemia (CML): a study of archival blood and bone marrow smears.
    Nguyen PL; Arthur DC; Litz CE; Brunning RD
    Leukemia; 1994 Oct; 8(10):1654-62. PubMed ID: 7934161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mixed phenotype (T/B/myeloid) extramedullary blast crisis as an initial presentation of chronic myelogenous leukemia.
    Qing X; Qing A; Ji P; French SW; Mason H
    Exp Mol Pathol; 2018 Apr; 104(2):130-133. PubMed ID: 29501750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percentage of S-phase cells in bone marrow aspirates, biopsy specimens and bone marrow aspirates corrected for blood dilution from patients with acute leukemia.
    Colly LP; Peters WG; Hermans J; Arentsen-Honders W; Willemze R
    Leuk Res; 1987; 11(3):209-13. PubMed ID: 3470574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Parameters of granulocyte proliferation in chronic myeloid leukemia and their prognostic value].
    Kote'lnikov VM; Khoroshko ND
    Gematol Transfuziol; 1989 Aug; 34(8):7-10. PubMed ID: 2583453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal expression of N-CAM (CD56) adhesion molecule on myeloid and progenitor cells from chronic myeloid leukemia.
    Lanza F; Bi S; Castoldi G; Goldman JM
    Leukemia; 1993 Oct; 7(10):1570-5. PubMed ID: 7692192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow core biopsy in 508 consecutive patients with chronic myeloid leukemia: Assessment of potential value.
    Hidalgo-Lόpez JE; Kanagal-Shamanna R; Quesada AE; Gong Z; Wang W; Hu S; Medeiros LJ; Bassett RL; d'Orcy E; Yin CC; Cortes J; Jabbour EJ; Kantarjian HM; Bueso-Ramos CE
    Cancer; 2018 Oct; 124(19):3849-3855. PubMed ID: 30321462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. t(8;21)(q22;q22) in blast phase of chronic myelogenous leukemia.
    Yin CC; Medeiros LJ; Glassman AB; Lin P
    Am J Clin Pathol; 2004 Jun; 121(6):836-42. PubMed ID: 15198355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of peripheral blood, bone marrow aspirate and especially bone marrow trephine biopsy in distinguishing atypical chronic myeloid leukemia from chronic granulocytic leukemia and chronic myelomonocytic leukemia.
    Xubo G; Xingguo L; Xianguo W; Rongzhen X; Xibin X; Lin W; Lei Z; Xiaohong Z; Genbo X; Xiaoying Z
    Eur J Haematol; 2009 Oct; 83(4):292-301. PubMed ID: 19500135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD34 immunostaining of bone marrow biopsy specimens is a reliable way to classify the phases of chronic myeloid leukemia.
    Orazi A; Neiman RS; Cualing H; Heerema NA; John K
    Am J Clin Pathol; 1994 Apr; 101(4):426-8. PubMed ID: 7512785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normalization of bone marrow aspirates for hemodilution in flow cytometric analyses.
    Loken MR; Chu SC; Fritschle W; Kalnoski M; Wells DA
    Cytometry B Clin Cytom; 2009 Jan; 76(1):27-36. PubMed ID: 18548614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow biopsy instead of 'marrow juice' for cell kinetic analysis. Comparison of bone marrow biopsy and aspiration material.
    Hiddemann W; Büchner T; Andreeff M; Wörmann B; Melamed MR; Clarkson BD
    Leuk Res; 1982; 6(4):601-12. PubMed ID: 6183535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow cytometric assessment of peripheral blood contamination and proliferative activity of human bone marrow cell populations.
    Abrahamsen JF; Lund-Johansen F; Laerum OD; Schem BC; Sletvold O; Smaaland R
    Cytometry; 1995 Jan; 19(1):77-85. PubMed ID: 7705188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of proliferating cells in acute leukemia with antibodies to proliferating cell nuclear antigen and Ki-67 monoclonal antibodies.
    Inoue T; Yamane T; Park K; Im T; Tatsumi N; Okuda K
    Arch Pathol Lab Med; 1993 Oct; 117(10):969-72. PubMed ID: 8105766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graft-versus-leukemia target antigens in chronic myelogenous leukemia are expressed on myeloid progenitor cells.
    Wu CJ; Biernacki M; Kutok JL; Rogers S; Chen L; Yang XF; Soiffer RJ; Ritz J
    Clin Cancer Res; 2005 Jun; 11(12):4504-11. PubMed ID: 15958636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of non-Hodgkin lymphoma in a patient with chronic myeloid leukemia.
    Găman AM; Dobrea C; Rotaru I
    Rom J Morphol Embryol; 2013; 54(4):1141-5. PubMed ID: 24399014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA-flow cytometry of blood and bone marrow in chronic myelogenous leukemia.
    Holdrinet RS; Pennings A; van Egmond J; Wessels JM; Haanen C
    Acta Haematol; 1983; 69(2):98-105. PubMed ID: 6404095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormality of c-kit oncoprotein in certain patients with chronic myelogenous leukemia--potential clinical significance.
    Inokuchi K; Yamaguchi H; Tarusawa M; Futaki M; Hanawa H; Tanosaki S; Dan K
    Leukemia; 2002 Feb; 16(2):170-7. PubMed ID: 11840282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic myeloid leukemia following therapy with imatinib mesylate (Gleevec). Bone marrow histopathology and correlation with genetic status.
    Frater JL; Tallman MS; Variakojis D; Druker BJ; Resta D; Riley MB; Hrisinko MA; Peterson LC
    Am J Clin Pathol; 2003 Jun; 119(6):833-41. PubMed ID: 12817431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.